Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C J Jolles

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
Fertility and Sterility|August 1, 1992
Pseudomyxoma peritonei associated with secondary infertilityH A Hales, C M Peterson, C J Jolles, et al.
Oncology Research|January 1, 1996
Elevations of DNA topoisomerase I catalytic activity and immunoprotein in human malignanciesI B Bronstein, S Vorobyev, A Timofeev, et al.
Photochemistry and Photobiology|April 1, 1989
Systemic immunosuppression induced by photodynamic therapy (PDT) is adoptively transferred by macrophagesD H Lynch, S Haddad, V J King, et al.
American Journal of Obstetrics and Gynecology|December 1, 1992
Photodynamic therapy of human ovarian epithelial carcinoma, OVCAR-3, heterotransplanted in the nude mouseC M Peterson, R Reed, C J Jolles, et al.
The New England Journal of Medicine|January 8, 1976
A comparison of early-onset group B streptococcal neonatal infection and the respiratory-distress syndrome of the newbornR C Ablow, S G Driscoll, E L Effmann, et al.
Gynecologic Oncology|January 1, 1994
GnRH agonist therapy in human ovarian epithelial carcinoma (OVCAR-3) heterotransplanted in the nude mouse is characterized by latency and transienceC M Peterson, C J Jolles, D T Carrell, et al.
Cancer Treatment Reports|March 1, 1986
Ethinyl estradiol and medroxyprogesterone acetate in patients with epithelial ovarian carcinoma: a phase II studyR S Freedman, P B Saul, C L Edwards, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1992
Improved therapeutic index of carboplatin plus cyclophosphamide versus cisplatin plus cyclophosphamide: final report by the Southwest Oncology Group of a phase III randomized trial in stages III and IV ovarian cancerD S Alberts, S Green, E V Hannigan, et al.
Cancer|January 15, 1993
Analysis of patient age as an independent prognostic factor for survival in a phase III study of cisplatin-cyclophosphamide versus carboplatin-cyclophosphamide in stages III (suboptimal) and IV ovarian cancer. A Southwest Oncology Group studyD S Alberts, S Dahlberg, S J Green, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Fertility and Sterility|August 1, 1992
Pseudomyxoma peritonei associated with secondary infertilityH A Hales, C M Peterson, C J Jolles, et al.
Oncology Research|January 1, 1996
Elevations of DNA topoisomerase I catalytic activity and immunoprotein in human malignanciesI B Bronstein, S Vorobyev, A Timofeev, et al.
Photochemistry and Photobiology|April 1, 1989
Systemic immunosuppression induced by photodynamic therapy (PDT) is adoptively transferred by macrophagesD H Lynch, S Haddad, V J King, et al.
American Journal of Obstetrics and Gynecology|December 1, 1992
Photodynamic therapy of human ovarian epithelial carcinoma, OVCAR-3, heterotransplanted in the nude mouseC M Peterson, R Reed, C J Jolles, et al.
The New England Journal of Medicine|January 8, 1976
A comparison of early-onset group B streptococcal neonatal infection and the respiratory-distress syndrome of the newbornR C Ablow, S G Driscoll, E L Effmann, et al.
Gynecologic Oncology|January 1, 1994
GnRH agonist therapy in human ovarian epithelial carcinoma (OVCAR-3) heterotransplanted in the nude mouse is characterized by latency and transienceC M Peterson, C J Jolles, D T Carrell, et al.
Cancer Treatment Reports|March 1, 1986
Ethinyl estradiol and medroxyprogesterone acetate in patients with epithelial ovarian carcinoma: a phase II studyR S Freedman, P B Saul, C L Edwards, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1992
Improved therapeutic index of carboplatin plus cyclophosphamide versus cisplatin plus cyclophosphamide: final report by the Southwest Oncology Group of a phase III randomized trial in stages III and IV ovarian cancerD S Alberts, S Green, E V Hannigan, et al.
Cancer|January 15, 1993
Analysis of patient age as an independent prognostic factor for survival in a phase III study of cisplatin-cyclophosphamide versus carboplatin-cyclophosphamide in stages III (suboptimal) and IV ovarian cancer. A Southwest Oncology Group studyD S Alberts, S Dahlberg, S J Green, et al.
Pageof 2